Ipsen Sa Stock Performance
| IPSEF Stock | USD 113.13 4.47 3.80% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Ipsen SA are completely uncorrelated. Ipsen SA right now retains a risk of 0.0%. Please check out Ipsen SA daily balance of power and period momentum indicator , to decide if Ipsen SA will be following its current trending patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Ipsen SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Ipsen SA is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Ipsen |
Ipsen SA Relative Risk vs. Return Landscape
If you would invest 11,313 in Ipsen SA on October 23, 2025 and sell it today you would earn a total of 0.00 from holding Ipsen SA or generate 0.0% return on investment over 90 days. Ipsen SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Ipsen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ipsen SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ipsen SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ipsen SA, and traders can use it to determine the average amount a Ipsen SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IPSEF |
Based on monthly moving average Ipsen SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ipsen SA by adding Ipsen SA to a well-diversified portfolio.
Ipsen SA Fundamentals Growth
Ipsen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ipsen SA, and Ipsen SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ipsen Pink Sheet performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 8.89 B | |||
| Shares Outstanding | 82.64 M | |||
| Price To Earning | 11.18 X | |||
| Price To Book | 2.38 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 3.16 B | |||
| EBITDA | 1.06 B | |||
| Cash And Equivalents | 1.07 B | |||
| Cash Per Share | 12.95 X | |||
| Total Debt | 562.8 M | |||
| Debt To Equity | 0.38 % | |||
| Book Value Per Share | 40.53 X | |||
| Cash Flow From Operations | 971.4 M | |||
| Earnings Per Share | 8.87 X | |||
| Total Asset | 5.61 B | |||
| Retained Earnings | 133 M | |||
| Current Asset | 964 M | |||
| Current Liabilities | 433 M | |||
About Ipsen SA Performance
By analyzing Ipsen SA's fundamental ratios, stakeholders can gain valuable insights into Ipsen SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ipsen SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ipsen SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen Sa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4500 people.Things to note about Ipsen SA performance evaluation
Checking the ongoing alerts about Ipsen SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ipsen SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ipsen SA generated a negative expected return over the last 90 days | |
| About 57.0% of the company shares are held by company insiders | |
| Latest headline from medcitynews.com: Takeda RD Exec Explains How 1.2B Deal Could Become One of the Biggest Bargains in Drug History |
- Analyzing Ipsen SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ipsen SA's stock is overvalued or undervalued compared to its peers.
- Examining Ipsen SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ipsen SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ipsen SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ipsen SA's pink sheet. These opinions can provide insight into Ipsen SA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ipsen Pink Sheet analysis
When running Ipsen SA's price analysis, check to measure Ipsen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ipsen SA is operating at the current time. Most of Ipsen SA's value examination focuses on studying past and present price action to predict the probability of Ipsen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ipsen SA's price. Additionally, you may evaluate how the addition of Ipsen SA to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |